{ "items": [ "\n\n
Price A. et al, (2019), Health technology assessment (Winchester, England), 23, 1 - 216
\n \n \n \n\n \n
\n \n \nABEL L. et al, (2019), International Journal of Technology Assessment in Health Care
\n \n \n \n\n \n
\n \n \nReed SD. et al, (2018), DIABETOLOGIA, 61, S426 - S426
\n \n \n \n\n \n
\n \n \nBecker F. et al, (2018), DIABETOLOGIA, 61, S366 - S366
\n \n \n \n\n \n
\n \n \nDakin HA. et al, (2018), Trials
\n \n \n \n\n \n
\n \n \nReed SD. et al, (2018), DIABETES, 67
\n \n \n \n\n \n
\n \n \nDakin HA. and Gray A., (2018), Medical Decision Making
\n \n \n \n\n \n
\n \n \nEibich P. et al, (2018), BMJ open, 8, e019477 - e019477
\n \n \n \n\n \n
\n \n \nDakin HA. et al, (2018), Health and Quality of Life Outcomes
\n \n \n \n\n \n
\n \n \nGRAY A., (2017), Health and quality of life outcomes, 15, 185 - 185
\n \n \n \n\n \n
\n \n \nDakin HA. and Gray A., (2017), Statistics in Medicine
\n \n \n \n\n \n
\n \n \nReeves BC. et al, (2016), Health Technol Assess, 20, 1 - 120
\n \n \n \n\n \n
\n \n \nViolato M. et al, (2016), BMJ Open
\n \n \n \n\n \n
\n \n \nReeves BC. et al, (2016), Health technology assessment (Winchester, England), 20, 1 - 120
\n \n \n \n\n \n
\n \n \nDixon P. et al, (2016), Qual Life Res, 25, 935 - 945
\n \n \n \n\n \n
\n \n \nPetrou S. et al, (2016), Quality of Life Research, 25, 275 - 281
\n \n \n \n\n \n
\n \n \nChakravarthy U. et al, (2015), Health Technol Assess, 19, 1 - 298
\n \n \n \n\n \n
\n \n \nDakin H. et al, (2015), Health Econ, 24, 1256 - 1271
\n \n \n \n\n \n
\n \n \nPetrou S. et al, (2015), Health Qual Life Outcomes, 13
\n \n \n \n\n \n
\n \n \nPetrou S. et al, (2015), Applied Health Economics and Health Policy, 13, 437 - 443
\n \n \n \n\n \n
\n \n \n